StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > How long before covid-19test sales start to dry up for SZLS?

<< Previous

Bullboard Posts

Next >>

Comment by StockscoutXon Jun 09, 2021 4:17pm

85 Views

Post# 33356953

RE:RE:How long before covid-19test sales start to dry up for SZLS?

All the pumping and name calling gojotv! will not help you recover your losses. It's a fact that StageZero has a pricey test kit and competitors with better pricing could easily cut into their actual market share going forward. It doesn't look good going forward for revenue making on convid-19 tests for StageZero. They better get up to speed with Aristotle or else they will be checkmated by another competitor in the same field.

gojotv! wrote: Now that you've read StockscumX's lies, here's the truth.
Covid tests have a wide price range because there are different kinds of tests. For travel, a PCR test from a recognized lab is needed, not a cheaper antigen test.
As for duration...Mexico and Southern destinations have been hit hard by Covid. Florida and Disney destinations DO NOT want the scandal of being "spreader" destinations.
Testing will be mandatory over the winter at least. After that, it's possible that testing remains, depending on vaccine efficiency.
But we can count on nice, fat profits from that sector until Aristotle gets its chance to establish itself as the premier pan-cancer diagnostic test worldwide.
Basically, SZLS is now in the black for good, and heading for green... and then GOLD!

StockscoutX wrote: StageZero has serious competition.

Here is an excerpt:

How much does a viral test for COVID-19 cost?

There is a wide range in charges. An investigation by the Kaiser Family Foundation determined that the cost of a test can range anywhere from $20 to $850, with $127 being the median cost. Currently, the Medicare reimbursement rate for a COVID-19 test is either $51 or $100, depending on the type of test offered. For those who end up paying out of pocket, there was a smaller range of $36 to $180 per test. Again, any test would also likely require additional charges for specimen collection and a physician’s visit, which could potentially add to the cost significantly.

Here is the link:
Q&A: How much does it cost to get a COVID-19 test? It depends. - Johns Hopkins Coronavirus Resource Center (jhu.edu)

or

https://coronavirus.jhu.edu/from-our-experts/q-and-a-how-much-does-it-cost-to-get-a-covid-19-test-it-depends